Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2021

SELL
$43.09 - $82.26 $1.98 Million - $3.79 Million
-46,044 Closed
0 $0
Q2 2021

Jul 29, 2021

SELL
$52.03 - $68.77 $102,863 - $135,958
-1,977 Reduced 4.12%
46,044 $3 Million
Q1 2021

May 14, 2021

BUY
$43.96 - $55.99 $8,132 - $10,358
185 Added 0.39%
48,021 $2.52 Million
Q4 2020

Feb 16, 2021

BUY
$27.19 - $44.68 $231,550 - $380,494
8,516 Added 21.66%
47,836 $2.14 Million
Q3 2020

Nov 16, 2020

BUY
$27.01 - $37.31 $95,696 - $132,189
3,543 Added 9.9%
39,320 $1.14 Million
Q2 2020

Aug 14, 2020

BUY
$32.85 - $53.77 $799,963 - $1.31 Million
24,352 Added 213.15%
35,777 $1.27 Million
Q1 2020

May 15, 2020

BUY
$32.63 - $67.59 $372,797 - $772,215
11,425 New
11,425 $590,000

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $214M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Rice Hall James & Associates, LLC Portfolio

Follow Rice Hall James & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.